Quintás-Cardama, A., Cortes, J. E., O'Brien, S., Ravandi, F., Borthakur, G., Liu, D., . . . Kantarjian, H. M. (2009). Dasatinib Early Intervention After Cytogenetic or Hematologic Resistance to Imatinib in Patients With Chronic Myeloid Leukemia.
Styl cytowania ChicagoQuintás-Cardama, Alfonso, Jorge E. Cortes, Susan O'Brien, Farhad Ravandi, Gautam Borthakur, David Liu, Eric Bleickardt, Tai-Tsang Chen, i Hagop M. Kantarjian. Dasatinib Early Intervention After Cytogenetic or Hematologic Resistance to Imatinib in Patients With Chronic Myeloid Leukemia. 2009.
Styl cytowania MLAQuintás-Cardama, Alfonso, et al. Dasatinib Early Intervention After Cytogenetic or Hematologic Resistance to Imatinib in Patients With Chronic Myeloid Leukemia. 2009.
Uwaga: Te cytaty mogą odróżniać się od wytycznej twojego fakultetu..